vs
费森尤斯医疗（FMS）与史丹利百得（SWK）财务数据对比。点击上方公司名可切换其他公司
费森尤斯医疗的季度营收约是史丹利百得的1.5倍（$5.5B vs $3.8B），费森尤斯医疗净利率更高（7.9% vs 1.4%，领先6.6%），史丹利百得同比增速更快（0.1% vs -0.3%）
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
史丹利百得是美国知名的工业工具、家用五金产品制造商，同时提供安防类产品，前身为史丹利工具有限公司，由史丹利与百得于2010年3月12日合并而来，总部位于康涅狄格州大哈特福德地区的新不列颠市。
FMS vs SWK — 直观对比
营收规模更大
FMS
是对方的1.5倍
$3.8B
营收增速更快
SWK
高出0.4%
-0.3%
净利率更高
FMS
高出6.6%
1.4%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.5B | $3.8B |
| 净利润 | $434.2M | $51.4M |
| 毛利率 | 27.4% | 31.4% |
| 营业利润率 | 11.7% | — |
| 净利率 | 7.9% | 1.4% |
| 营收同比 | -0.3% | 0.1% |
| 净利润同比 | 240.4% | -43.6% |
| 每股收益（稀释后） | — | $0.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FMSSWK
| Q4 25 | $5.5B | — | ||
| Q3 25 | — | $3.8B | ||
| Q2 25 | — | $3.9B | ||
| Q1 25 | — | $3.7B | ||
| Q4 24 | $5.5B | $3.7B | ||
| Q3 24 | — | $3.8B | ||
| Q2 24 | — | $4.0B | ||
| Q1 24 | — | $3.9B |
净利润FMSSWK
| Q4 25 | $434.2M | — | ||
| Q3 25 | — | $51.4M | ||
| Q2 25 | — | $101.9M | ||
| Q1 25 | — | $90.4M | ||
| Q4 24 | $127.6M | $194.9M | ||
| Q3 24 | — | $91.1M | ||
| Q2 24 | — | $-11.2M | ||
| Q1 24 | — | $19.5M |
毛利率FMSSWK
| Q4 25 | 27.4% | — | ||
| Q3 25 | — | 31.4% | ||
| Q2 25 | — | 27.0% | ||
| Q1 25 | — | 29.9% | ||
| Q4 24 | 25.0% | 30.8% | ||
| Q3 24 | — | 29.9% | ||
| Q2 24 | — | 28.4% | ||
| Q1 24 | — | 28.6% |
营业利润率FMSSWK
| Q4 25 | 11.7% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.1% | 3.4% | ||
| Q3 24 | — | 10.6% | ||
| Q2 24 | — | 9.5% | ||
| Q1 24 | — | 8.3% |
净利率FMSSWK
| Q4 25 | 7.9% | — | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | 2.3% | 5.2% | ||
| Q3 24 | — | 2.4% | ||
| Q2 24 | — | -0.3% | ||
| Q1 24 | — | 0.5% |
每股收益（稀释后）FMSSWK
| Q4 25 | — | — | ||
| Q3 25 | — | $0.34 | ||
| Q2 25 | — | $0.67 | ||
| Q1 25 | — | $0.60 | ||
| Q4 24 | — | $1.29 | ||
| Q3 24 | — | $0.60 | ||
| Q2 24 | — | $-0.07 | ||
| Q1 24 | — | $0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $268.3M |
| 总债务越低越好 | — | $5.3B |
| 股东权益账面价值 | $15.4B | $9.0B |
| 总资产 | $33.5B | $21.8B |
| 负债/权益比越低杠杆越低 | — | 0.59× |
8季度趋势，按日历期对齐
现金及短期投资FMSSWK
| Q4 25 | $1.7B | — | ||
| Q3 25 | — | $268.3M | ||
| Q2 25 | — | $311.8M | ||
| Q1 25 | — | $344.8M | ||
| Q4 24 | $1.3B | $290.5M | ||
| Q3 24 | — | $298.7M | ||
| Q2 24 | — | $318.5M | ||
| Q1 24 | — | $476.6M |
总债务FMSSWK
| Q4 25 | — | — | ||
| Q3 25 | — | $5.3B | ||
| Q2 25 | — | $5.6B | ||
| Q1 25 | — | $5.6B | ||
| Q4 24 | — | $6.1B | ||
| Q3 24 | — | $6.1B | ||
| Q2 24 | — | $6.1B | ||
| Q1 24 | — | $6.1B |
股东权益FMSSWK
| Q4 25 | $15.4B | — | ||
| Q3 25 | — | $9.0B | ||
| Q2 25 | — | $9.1B | ||
| Q1 25 | — | $8.8B | ||
| Q4 24 | $17.0B | $8.7B | ||
| Q3 24 | — | $8.9B | ||
| Q2 24 | — | $8.7B | ||
| Q1 24 | — | $8.9B |
总资产FMSSWK
| Q4 25 | $33.5B | — | ||
| Q3 25 | — | $21.8B | ||
| Q2 25 | — | $22.5B | ||
| Q1 25 | — | $22.5B | ||
| Q4 24 | $36.3B | $21.8B | ||
| Q3 24 | — | $22.5B | ||
| Q2 24 | — | $22.5B | ||
| Q1 24 | — | $23.9B |
负债/权益比FMSSWK
| Q4 25 | — | — | ||
| Q3 25 | — | 0.59× | ||
| Q2 25 | — | 0.62× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.70× | ||
| Q3 24 | — | 0.69× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.69× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.9B | $221.2M |
| 自由现金流经营现金流 - 资本支出 | — | $155.3M |
| 自由现金流率自由现金流/营收 | — | 4.1% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | 6.67× | 4.30× |
| 过去12个月自由现金流最近4个季度 | — | $369.6M |
8季度趋势，按日历期对齐
经营现金流FMSSWK
| Q4 25 | $2.9B | — | ||
| Q3 25 | — | $221.2M | ||
| Q2 25 | — | $214.3M | ||
| Q1 25 | — | $-420.0M | ||
| Q4 24 | $2.6B | $679.1M | ||
| Q3 24 | — | $285.8M | ||
| Q2 24 | — | $573.0M | ||
| Q1 24 | — | $-431.0M |
自由现金流FMSSWK
| Q4 25 | — | — | ||
| Q3 25 | — | $155.3M | ||
| Q2 25 | — | $134.7M | ||
| Q1 25 | — | $-485.0M | ||
| Q4 24 | — | $564.6M | ||
| Q3 24 | — | $199.3M | ||
| Q2 24 | — | $485.8M | ||
| Q1 24 | — | $-496.7M |
自由现金流率FMSSWK
| Q4 25 | — | — | ||
| Q3 25 | — | 4.1% | ||
| Q2 25 | — | 3.4% | ||
| Q1 25 | — | -13.0% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | — | 12.1% | ||
| Q1 24 | — | -12.8% |
资本支出强度FMSSWK
| Q4 25 | — | — | ||
| Q3 25 | — | 1.8% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 1.7% | ||
| Q4 24 | — | 3.1% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 2.2% | ||
| Q1 24 | — | 1.7% |
现金转化率FMSSWK
| Q4 25 | 6.67× | — | ||
| Q3 25 | — | 4.30× | ||
| Q2 25 | — | 2.10× | ||
| Q1 25 | — | -4.65× | ||
| Q4 24 | 20.20× | 3.48× | ||
| Q3 24 | — | 3.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | -22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMS
暂无分部数据
SWK
| Tools And Outdoor Segment | $3.3B | 87% |
| Engineered Fastening Segment | $500.5M | 13% |
